Mangoceuticals, Inc.
MGRX
$0.15
Change (1 day)
$16.80
Year High
$2.10
Year Low
Categories
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Revenue of Mangoceuticals, Inc. (MGRX)
Revenue in 2023 (TTM): $731.49 K
According to Mangoceuticals, Inc.'s latest financial reports the company's current revenue (TTM) is $731.49 K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Mangoceuticals, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $731.49 K | $431.5 K | $-9,187,528 | $-9,212,417 | $-9,212,417 |
| 2022 | $8.94 K | $4.85 K | $-1,987,719 | $-1,998,055 | $-1,998,055 |
| 2021 | $ | $ | $52.56 K | $-17,701 | $-17,701 |